{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:20:41Z","timestamp":1767828041102,"version":"3.49.0"},"reference-count":34,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003827","name":"National Research, Development and Innovation Office of Hungary","doi-asserted-by":"publisher","award":["FK131916"],"award-info":[{"award-number":["FK131916"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Plexiform neurofibromas occurring in approximately 20\u201350% of all neurofibromatosis type-1 (NF1) cases are histologically benign tumors, but they can be fatal due to compression of vital structures or transformation to malignant sarcomas or malignant peripheral nerve sheath tumors. All sizeable plexiform neurofibromas are thought to result from an early second mutation giving rise to a loss of heterozygosity of the NF1 gene. In this unusual case, a 12-year-old girl presented with a rapidly growing, extremely extensive plexiform neurofibroma with segmental distribution over the entire right arm, extending to the right chest wall and mediastinum, superimposed on classic cutaneous lesions of NF1. After several surgical interventions, the patient was efficiently treated with an oral selective MEK inhibitor, selumetinib, which resulted in a rapid reduction of the tumor volume. Molecular analysis of the NF1 gene revealed a c.2326-2 A&gt;G splice-site mutation in the clinically unaffected skin, peripheral blood sample, and plexiform neurofibroma, which explains the general clinical symptoms. Furthermore, a novel likely pathogenic variant, c.4933dupC (p.Leu1645Profs*7), has been identified exclusively in the girl\u2019s plexiform neurofibromas. This second-hit mutation can explain the extremely extensive segmental involvement.<\/jats:p>","DOI":"10.3390\/ijms241512154","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T01:26:40Z","timestamp":1690766800000},"page":"12154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Superimposed Mosaicism in the Form of Extremely Extended Segmental Plexiform Neurofibroma Caused by a Novel Pathogenic Variant in the NF1 Gene"],"prefix":"10.3390","volume":"24","author":[{"given":"Kl\u00e1ra","family":"Veres","sequence":"first","affiliation":[{"name":"Department of Pediatric Dermatology, Heim Pal National Children\u2019s Institute, 1089 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5757-6244","authenticated-orcid":false,"given":"Judit","family":"Bene","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Clinical Center, Medical School, University of P\u00e9cs, 7622 P\u00e9cs, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2303-1670","authenticated-orcid":false,"given":"Kinga","family":"Hadzsiev","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Clinical Center, Medical School, University of P\u00e9cs, 7622 P\u00e9cs, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4298-2746","authenticated-orcid":false,"given":"Mikl\u00f3s","family":"Garami","sequence":"additional","affiliation":[{"name":"Pediatric Center, Faculty of Medicine, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1ra","family":"P\u00e1lla","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Happle","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical Center\u2013University of Freiburg, 79104 Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-096X","authenticated-orcid":false,"given":"M\u00e1rta","family":"Medvecz","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna Zs\u00f3fia","family":"Szalai","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, Heim Pal National Children\u2019s Institute, 1089 Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Imaz, E., Mart\u00edn, Y., de Conti, L., Melean, G., Valero, A., Baralle, M., and Hern\u00e1ndez-Chico, C. (2015). Functional analysis of mutations in exon 9 of NF1 reveals the presence of several elements regulating splicing. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141735"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.jaad.2020.07.105","article-title":"Neurofibromatosis type 1: New developments in genetics and treatment","volume":"84","author":"Wilson","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"P\u00e1lla, S., Anker, P., Farkas, K., Pl\u00e1z\u00e1r, D., Kiss, S., Marschalk\u00f3, P., Szalai, Z., Bene, J., Hadzsiev, K., and Mar\u00f3ti, Z. (2023). Co-occurrence of neurofibromatosis type 1 and pseudoachondroplasia\u2014A first case report. BMC Pediatr., 23.","DOI":"10.1186\/s12887-023-03920-7"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.2340\/actadv.v103.5758","article-title":"Characteristics of Caf\u00e9-au-lait Macules and their Association with the Neurofibromatosis type I Genotype in a Cohort of Greek Children","volume":"103","author":"Lamprini","year":"2023","journal-title":"Acta Derm.-Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1479-7364-6-12","article-title":"Genotype-phenotype associations in neurofibromatosis type 1 (NF1): An increased risk of tumor complications in patients with NF1 splice-site mutations?","volume":"6","author":"Alkindy","year":"2012","journal-title":"Hum. Genom."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000327379","article-title":"Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: A cross-sectional study of 728 patients","volume":"222","author":"Duong","year":"2011","journal-title":"Dermatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/088307380201700802","article-title":"Neurofibromatosis 1: Clinical manifestations and diagnostic criteria","volume":"17","author":"Friedman","year":"2002","journal-title":"J. Child Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3345\/cep.2020.00871","article-title":"Neurofibromatosis type I: Points to be considered by general pediatricians","volume":"64","author":"Kang","year":"2021","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: An international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1111\/jdv.14242","article-title":"At first sight or second glance: Clinical presentation of mosaic manifestations of autosomal dominant skin disorders\u2013A case series","volume":"31","author":"Toberer","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jaad.2007.03.013","article-title":"Giant caf\u00e9-au-lait macule in neurofibromatosis 1: A type 2 segmental manifestation of neurofibromatosis 1?","volume":"58","author":"Yang","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1002\/ajmg.a.62420","article-title":"Juvenile xanthogranuloma: A possible diagnostic criterion for Neurofibromatosis type 1 in young children","volume":"185","author":"Calligaris","year":"2021","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: A twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/1479-7364-5-6-623","article-title":"Neurofibromatosis type 1-associated tumours: Their somatic mutational spectrum and pathogenesis","volume":"5","author":"Spyk","year":"2011","journal-title":"Hum. Genom."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4314\/mmj.v30i1.11","article-title":"Large penile plexiform neurofibroma in an 11-year old boy","volume":"30","author":"Collins","year":"2018","journal-title":"Malawi Med. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1750-1172-7-75","article-title":"Growth dynamics of plexiform neurofibromas: A retrospective cohort study of 201 patients with neurofibromatosis 1","volume":"7","author":"Nguyen","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jpeds.2013.10.081","article-title":"Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type I","volume":"164","author":"Dagalakis","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2009.11.FOCUS09221","article-title":"Neurofibromatosis Type 1 and tumorigenesis: Molecular mechanisms and therapeutic implications","volume":"28","author":"Gottfried","year":"2010","journal-title":"Neurosurg. Focus"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Armstrong, A.E., Belzberg, A.J., Crawford, J.R., Hirbe, A.C., and Wang, Z.J. (2023). Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-10996-y"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/neuonc\/noac146","article-title":"Management of neurofibromatosis type 1-associated plexiform neurofibromas","volume":"24","author":"Fisher","year":"2022","journal-title":"Neuro-oncology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejca.2022.09.036","article-title":"Paediatric Strategy Forum for Medicinal Product Development in Mitogen-Activated Protein Kinase (MAPK) pathway inhibitors. ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration","volume":"177","author":"Pearson","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/10600280211046298","article-title":"A Review of Selumetinib in the Treatment of Neurofibromatosis Type 1\u2013Related Plexiform Neurofibromas","volume":"56","author":"Anderson","year":"2022","journal-title":"Ann. Pharmacother."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ge, L.-L., Xing, M.-Y., Zhang, H.-B., and Wang, Z.-C. (2022). Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development. Cancers, 14.","DOI":"10.3390\/cancers14184513"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/exd.14514","article-title":"Concomitant variants in NF1, LZTR1 and GNAZ genes probably contribute to the aggressiveness of plexiform neurofibroma and warrant treatment with MEK inhibitor","volume":"31","author":"Livneh","year":"2022","journal-title":"Exp. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1038\/onc.2016.464","article-title":"The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas","volume":"36","author":"Pemov","year":"2017","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/515504","article-title":"Confirmation of a double-hit model for the NF1Gene in benign neurofibromas","volume":"61","author":"Serra","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1002\/humu.20793","article-title":"Germline and somatic NF1 gene mutations in plexiform neurofibromas","volume":"29","author":"Upadhyaya","year":"2008","journal-title":"Hum. Mutat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/gcc.20353","article-title":"Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients","volume":"45","author":"Maertens","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jid.2008.274","article-title":"Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas","volume":"129","author":"Steinmann","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/archderm.1997.03890480025004","article-title":"A rule concerning the segmental manifestation of autosomal dominant skin disorders: Review of clinical examples providing evidence for dichotomous types of severity","volume":"133","author":"Happle","year":"1997","journal-title":"Arch. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ajmg.a.37439","article-title":"The categories of cutaneous mosaicism: A proposed classification","volume":"170","author":"Happle","year":"2016","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: Statistical study of retinoblastoma","volume":"68","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Happle, R. (2014). Mosaicism in Human Skin, Springer.","DOI":"10.1007\/978-3-642-38765-4"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1111\/jdv.16603","article-title":"Superimposed mosaicism in tuberous sclerosis complex: A key to understanding all of the manifold manifestations?","volume":"34","author":"Happle","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/15\/12154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:22:05Z","timestamp":1760127725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/15\/12154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":34,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["ijms241512154"],"URL":"https:\/\/doi.org\/10.3390\/ijms241512154","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,29]]}}}